PCM
NVO

Parsons Capital Management’s Novo Nordisk NVO Stock Holding History

Parsons Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,490
Closed -$203K – 334
2015
Q3 		$203K Buy
+7,490
New +$212K 0.03% 319
2015
Q2 		– Sell
-2,400
Closed -$64K – 467
2015
Q1 		$64K Buy
+2,400
New +$55.3K 0.01% 442

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Parsons Capital Management's NVO Position: Q4 2015 in Review

Parsons Capital Management sold out of Novo Nordisk (NVO) in Q4 2015, closing a stake of 7,490 shares — an estimated $203K sold.

Parsons Capital Management first reported a position in NVO in Q1 2015 and held it in 2 quarters. The position peaked at $203K in Q3 2015. 548 funds tracked by Wall St. Rank hold NVO as of Q4 2015.

  • Parsons Capital Management reported no remaining Novo Nordisk position as of Q4 2015 after selling out during the quarter.
  • Parsons Capital Management sold 7,490 Novo Nordisk shares in Q4 2015, an estimated $203K.
  • Parsons Capital Management first reported a position in Novo Nordisk in Q1 2015 and held it in 2 quarters.
  • Parsons Capital Management's Novo Nordisk position peaked at $203K in Q3 2015.
  • 548 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2015.

Based on Parsons Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.